Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Methylprednisolone Acetate (Injection) bulk supplier for pharma manufacturers

Methylprednisolone Acetate (Injection) Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 40 mg/mL, 80 mg/mL, 125 mg/2 mL

Reference Brands: Depo-Medrol(US)

Category: Arthritis

Methylprednisolone acetate injection is a corticosteroid that suppresses inflammation by reducing immune response and inflammatory gene expression. It provides rapid relief for severe flare-ups, joint pain, and swelling. Benefits include targeted, fast-acting anti-inflammatory effects, improved joint mobility, and effective long-term disease management when used under medical supervision.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Methylprednisolone acetate injection is approved in the EU and US for severe inflammatory and autoimmune conditions. In the EU, brands like Solu-Medrol are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for approval and continuous pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We streamline global market access for methylprednisolone acetate injections, ensuring adherence to European and American standards for safe, effective corticosteroid therapy, helping you navigate complex regulatory landscapes seamlessly.

Methylprednisolone Acetate (Injection) — third party manufacturing & bulk supply

Methylprednisolone Acetate (Injection) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Methylprednisolone Acetate (Injection) is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Methylprednisolone Acetate (Injection) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Methylprednisolone Acetate (Injection) →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Methylprednisolone Acetate (Injection) is listed as Injection in 40 mg/mL, 80 mg/mL, 125 mg/2 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Methylprednisolone Acetate (Injection) is referenced against Depo-Medrol(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Methylprednisolone Acetate (Injection) is catalogued under Arthritis on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Pegloticase Injecatble

Strength:
8 mg/1.2 mL vial

Form: Injectable (IV solution)

Reference Brands: Krystexxa (US)

View Details
Colchicine Tablest

Strength:
0.6 mg

Form: Tablet

Reference Brands: Colcrys(US)

View Details
Febuxostat Tablets

Strength:
40 mg, 80 mg

Form: Oral Tablets

Reference Brands: Uloric(EU & US)

View Details
Allopurinol Tablets

Strength:
100 mg, 300 mg

Form: Oral Tablets

Reference Brands: Aloprim(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.